Apolipoproteins A1, B, and apoB/apoA1 ratio are associated with first ST-segment elevation myocardial infarction but not with recurrent events during long-term follow-up

INTRODUCTION: The current way to assess the risk of cardiovascular disease (CVD) is to measure conventional lipid and lipoprotein cholesterol fractions. Despite the success of statin treatment, residual cardiovascular risk remains high. Therefore, the value of extensive serum apolipoprotein (apo) pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bodde, Mathijs C., Hermans, Maaike P. J., Jukema, J. Wouter, Schalij, Martin J., Lijfering, Willem M., Rosendaal, Frits R., Romijn, Fred P. H. T. M., Ruhaak, L. Renee, van der Laarse, Arnoud, Cobbaert, Christa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484771/
https://www.ncbi.nlm.nih.gov/pubmed/30298424
http://dx.doi.org/10.1007/s00392-018-1381-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484771/
https://www.ncbi.nlm.nih.gov/pubmed/30298424
http://dx.doi.org/10.1007/s00392-018-1381-5

Ejemplares similares